评估HIV-1感染与常见鼻咽部细菌定植密度对接种7价肺炎球菌结合疫苗的南非儿童的影响
研究分析了接种7价肺炎球菌结合疫苗(PCV-7)的南非HIV感染与未感染儿童在9月龄和16月龄时鼻咽部肺炎球菌及其他细菌定植的患病率和密度。9月龄时HIV感染儿童总体肺炎球菌定植患病率较低但定植密度较高,主要因PCV7血清型定植密度较高;16月龄时总体肺炎球菌无差异。结论认为HIV感染儿童残留PCV7血清型定植密度增高可能增加肺炎球菌疾病风险,需进一步研究。
要点
- 9月龄时HIV感染儿童总体肺炎球菌定植患病率58.6%,低于HIV未感染儿童的69.9%(p=0.02)。
- 9月龄时HIV感染儿童肺炎球菌定植平均log10密度4.81 CFU/ml,高于HIV未感染儿童的4.44 CFU/ml(p=0.014)。
- 16月龄时两组总体肺炎球菌定植患病率和密度无差异。
核心结论
- HIV感染儿童残留PCV7血清型定植密度增高可能使其肺炎球菌疾病风险更高。
- HIV感染儿童观察到的较高定植密度可能归因于HIV治疗和宿主免疫受损等因素的综合作用。
- 需进一步研究。
研究设计与样本
- 研究对接种PCV-7(6、10、14周龄)的南非HIV感染和HIV未感染儿童的存档鼻咽拭子进行定植患病率和密度调查,拭子采集于9月龄和16月龄。
- 研究期间索韦托儿童PCV免疫仅限于研究参与者,因疫苗尚未引入公共免疫规划。
主要发现
- 9月龄时HIV感染儿童总体肺炎球菌定植患病率58.6%,低于HIV未感染儿童的69.9%(p=0.02),主要因非疫苗血清型定植患病率较低(27.8% vs 40%,p=0.047)。
- 9月龄时HIV感染肺炎球菌定植儿童平均log10密度4.81 CFU/ml,高于HIV未感染定植儿童的4.44 CFU/ml(p=0.014),主要因PCV7血清型定植平均log10密度较高(4.21 vs 3.72 CFU/ml,p=0.014)。
- 16月龄时总体肺炎球菌定植患病率和密度无差异;非疫苗血清型定植患病率HIV未感染儿童(60.4%)仍为HIV感染儿童(50.9%)的1.7倍(p=0.049)。
- 9月龄和16月龄时HIV感染儿童流感嗜血杆菌定植患病率(42.3%和56%)均低于HIV未感染儿童(64.2%和73.4%),但定植密度相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Due to limitations in standard culture methods, the impact of pneumococcal conjugate vaccine (PCV) immunization on nasopharyngeal bacterial carriage density is unclear, including among HIV-infected children. METHODS: The prevalence and density of serotype/serogroup-specific pneumococcal and other nasopharyngeal colonizing bacteria were investigated in archived swabs of HIV-infected and HIV-uninfected, PCV-7 immunized (at 6, 10 and 14 weeks of age) South African children collected at 9 and 16 months of age. During the course of the study, PCV-immunization of children in Soweto was limited to study-participants, as the vaccine had not been introduced into the public immunization program. RESULTS: At 9 months of age, the prevalence of overall pneumococcal colonization was lower in HIV-infected (58.6%) than HIV-uninfected children (69.9%, p = 0.02), mainly due to lower prevalence of non-vaccine-serotype colonization (27.8% vs. 40%, respectively; p = 0.047). The mean-log10 density of pneumococcal colonization was, however, higher in HIV-infected (4.81 CFU/ml) than HIV-uninfected pneumococcal colonized children (4.44 CFU/ml; p = 0.014); mainly due to higher mean-log10 density of PCV7-serotype colonization (4.21 vs. 3.72 CFU/ml; p = 0.014). No difference in the prevalence or density of overall pneumococci was found at 16 months of age. The prevalence of non-vaccine serotype colonization remained 1.7 fold higher in HIV-uninfected (60.4%) than HIV-infected children (50.9%, p = 0.049). Other differences included a lower prevalence of H. influenzae colonization in HIV-infected (42.3% and 56%) than HIV-uninfected children (64.2% and 73.4%) at both 9 and 16 months of age respectively; however, the density of colonization was similar. CONCLUSION: Increased carriage density of residual PCV7-serotypes might cause HIV-infected children to have a higher risk of pneumococcal disease. The higher carriage density observed in HIV-infected children could be attributed to a combination of factors, including HIV treatment and impaired host immunity. Additional studies are needed.
引用
- Olwagen CP, Adrian PV, Madhi SA, et al. Evaluation of the impact of HIV-1 infection and density of common nasopharyngeal bacterial colonizers in South African children immunized with 7-valent pneumococcal conjugate vaccine. Vaccine. 2019. PMID: 31874779. doi:10.1016/j.vaccine.2019.12.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。